Publications by authors named "Carlos Mario Muneton"

Background: Among the chronic myeloproliferative neoplasms (MPNs) not associated with BCR-ABL mutations are polycythemia vera, primary myelofibrosis, and essential thrombocythemia. These diseases are caused by mutations in genes, such as the JAK2, MPL, and CALR genes, which participate in regulating the JAK-STAT signaling pathway.

Objective: This study aimed to establish the frequencies of mutations in the JAK2, MPL, and CALR genes in a group of Colombian patients with a negative clinical diagnosis of BCR-ABL chronic myeloproliferative neoplasms.

View Article and Find Full Text PDF

Introduction: Colorectal cancer has a high incidence in the world population. Different molecular pathways, such as chromosomal instability, microsatellite instability, and epigenetics are involved in its development. Objective: To perform molecular characterization in 44 individuals with sporadic colorectal cancer.

View Article and Find Full Text PDF

Introduction: TP53 is a tumor suppressor gene located on chromosome 17p13.1. This gene is essential for the control of cell cycle and has been found altered in about 50% of all tumor types.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Carlos Mario Muneton"

  • - Carlos Mario Muneton focuses on the molecular characterization and genetic profiling of various cancers, particularly myeloproliferative neoplasms and colorectal cancer, aimed at understanding mutation frequencies and their implications on disease pathology.
  • - His recent research includes studying the mutation profiles of JAK2, CALR, and MPL genes in Colombian patients without BCR-ABL, contributing to the knowledge of genetic underpinnings in chronic myeloproliferative neoplasms.
  • - Muneton also explores chromosomal abnormalities, such as aneuploidy of chromosome 17 and TP53 gene deletions, providing insights into the molecular mechanisms of solid tumors and their relevance in cancer diagnostics.